Eli Lilly’s (LLY) Mounjaro will be added to China’s state-run health insurance scheme for patients with type 2 diabetes beginning January 1, Andrew Silver of Reuters reports, citing a notice on the National Healthcare Security Administration’s website. The inclusion will make the drug more widely available to the public, but the increase in sales will likely be mitigated by lower prices.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LLY:
- LLY, PFE: Eli Lilly’s Mounjaro, Pfizer’s Cancer Drug Added to China’s State Insurance List
- Eli Lilly announces Phase 3 BRUIN CLL-314 met primary endpoint
- Eli Lilly, Pfizer, Johnson secure spots on China’s drug catalog, Bloomberg says
- Trump Weekly: President approves U.S. manufacturing of ‘tiny cars’
- Salesforce (CRM) Wins AstraZeneca Deal, Becomes the Unified Global Platform